Förvärvar Lendify Kvartalets utveckling har präglats av det stora förvärvet av Lendify som avslutade...
Carlsquare Equity Research sammanfattar sina första intryck av Ecoclimes kv2 2023-rapport som offent...
Dovre’s Q2 figures came in a bit better than we had estimated as Project Personnel continued to grow...
Redeye leaves a comment on the Q2 report published by Alzinova earlier today.
Circular Energy +51% vs. ABGSCe EBIT SEK -0.3m (ABGSCe -5.
ARR -1% below ABGSCe, revenues and adj. EBITDA bang in line Guidance reiterated; no improvement in b...
Calliditas sequential Q2 sales growth bounces back to just above the Q4 level (39%) after the softer...
Redeye's first comments on the Q2 report this morning.
Redeye concludes that Q2 was stronger than Redeye expected, with higher-than-expected revenues and l...
Redeye comments on Starbreeze strong Q2 report. Net sales of SEK43.
Redeye comments on Fragbite Groups Q2’23 report, which showed a bit lower sales and profitability le...
Redeye gives an initial take on Binero’s H1 2023 report, being the first time the company provides h...
Marimekko reported Q2 results above expectations. Q2 net sales came in line with our estimates while...
Redeye states that while Q2 was soft, it was due to a timing effect implying that Q3 will be strong.
Q2 revenues 2% below ABGSCe, EBIT 9% below Signs of improving paper demand positive, but not surpris...
Q2e: -2% organic growth, EBITA SEK 94m (-16% y-o-y) Keeping FY guidance should be supportive for est...
Redeye comments on Sozap’s Q2 results, which were somewhat better than expected.
Redeye endorses yesterday's news that Sprint Bioscience has licensed the global rights to its cancer...
Vow will report its Q2 2023 results on 23 August. We pencil in sales of NOK 435m (up 14% from H2 202...
Agilyx is reporting its H1 2023 results on 22 August, for which we pencil in revenue of USD 9m (18% ...
